Schedule 13G ownership disclosure

LOXO ONCOLOGY INC

Security class unavailable · CUSIP: 548862101

Event date: 2016-07-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,519,184
Percent of class
7.0100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001040188-16-000110
Form type
SC 13G
Filer
Loxo Oncology, Inc.
CIK
CIK 1581720
Filed
Sep 23, 2016
Reporting period
Jul 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub